TheProfitWatch

PSTV - PLUS THERAPEUTICS, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.47 0.06 (12.09%) 0.0 (0.0%) 0.0 (0.04%) 0.01 (1.64%) 0.02 (4.3%) 0.03 (7.05%) 0.0 (0.04%) 0.0 (0.64%)

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Category: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Market Period: Market

Earnings & Ratios

Basic EPS:
0.02
Diluted EPS:
-0.01
Basic P/E:
26.34
Diluted P/E:
-52.68
RSI(14) 1m:
46.9
VWAP:
0.53
RVol:

Events

Period Kind Movement Occurred At

Related News